{
  "id": "19babf1408e31f05",
  "title": "NanoViricides advances toward fully funded Phase II MPox trial in DRC",
  "description": "20260219T151500Z",
  "content": "",
  "source": "proactiveinvestors.com",
  "source_url": "https://www.proactiveinvestors.com/companies/news/1087630/nanoviricides-advances-toward-fully-funded-phase-ii-mpox-trial-in-drc.html",
  "published_at": "20260219T151500Z",
  "fetched_at": "2026-02-20T00:27:32.210173+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.proactiveinvestors.com/companies/news/1087630/nanoviricides-advances-toward-fully-funded-phase-ii-mpox-trial-in-drc.html",
    "url_mobile": "",
    "title": "NanoViricides advances toward fully funded Phase II MPox trial in DRC",
    "seendate": "20260219T151500Z",
    "socialimage": "https://cdn.proactiveinvestors.com/eyJidWNrZXQiOiJwYS1jZG4iLCJrZXkiOiJ1cGxvYWRcL05ld3NcL0ltYWdlXC8yMDI2XzAyXC9sV3liZjRjVWZOZFI5Rks4eVBhbjlEOHN3ZzUyVHZFRm11ak1qeU9WLmpwZyIsImVkaXRzIjp7InJlc2l6ZSI6eyJ3aWR0aCI6MTIwMCwiaGVpZ2h0Ijo2MzAsImZpdCI6ImNvdmVyIn19fQ==",
    "domain": "proactiveinvestors.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}